CSPC Pharma (01093) spent HK $29.8096 million to repurchase 6.44 million shares on September 17th.
Shiyao Group (01093) announced that the company spent HK$2980.96 million on September 17, 2024...
CSPC PHARMA (01093) announced that the company repurchased 6.44 million shares for a total of 29.8096 million Hong Kong dollars on September 17, 2024, with a buyback price of 4.58-4.66 Hong Kong dollars per share.
Related Articles
JW THERAP-B(02126): Tian Feng will be appointed as the Chief Executive Officer.
Opening bell guests (COST.US) exceed expectations in Q1 but market response is dull, concerns arise over slowing membership renewal rates and high valuation.
CHAOJU EYE CARE (02219) repurchased 120,000 shares on December 11th for a total of HK$320,300.
JW THERAP-B(02126): Tian Feng will be appointed as the Chief Executive Officer.
Opening bell guests (COST.US) exceed expectations in Q1 but market response is dull, concerns arise over slowing membership renewal rates and high valuation.
CHAOJU EYE CARE (02219) repurchased 120,000 shares on December 11th for a total of HK$320,300.
RECOMMEND
McDonald’s to Evaluate Franchisee Pricing for Customer Value Under Revised Standards
10/12/2025
Baidu’s AI Ace Kunlunxin Prepares For Hong Kong IPO, Domestic Computing Power Faces Crucial Test
08/12/2025
Institutions Say Short-Term Volatility Does Not Alter Upward Trend Of Hong Kong Stocks, Hang Seng Index Still Expected To Challenge 30,000 Points Next Year
08/12/2025
